Status:
COMPLETED
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Vision Disorders
Eligibility:
All Genders
30-40 years
Phase:
NA
Brief Summary
This study is being conducted to evaluate Bausch \& Lomb PureVision Multi-Focal contact lenses compared to the Bausch \& Lomb SofLens59 contact lens when worn by adapted soft contact lens wearers on a...
Eligibility Criteria
Inclusion
- Subjects must have clear central corneas and be free of any anterior segment disorders.
- Subjects must be adapted soft contact lens wearers and agree to wear the study lenses on a daily wear basis for at least eight hours a day for approximately two weeks.
- Subjects must wear a lens in each eye and each lens must be of the same manufacture and brand.
Exclusion
- Subjects participating in any drug or device clinical investigation within two weeks prior to entry into this study and/or during the period of study participation.
- Subjects with any systemic disease affecting ocular health
- Subjects with an active ocular disease or using any ocular medication.
- Subjects who have had any corneal surgery (eg, refractive surgery).
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
272 Patients enrolled
Trial Details
Trial ID
NCT00985231
Start Date
September 1 2009
End Date
December 1 2009
Last Update
March 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bausch & Lomb
Rochester, New York, United States, 14609